Interleukin-2 Treatment for Wiskott-Aldrich Syndrome (WAS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2015 by Children's Hospital of Philadelphia
Sponsor:
Collaborator:
Texas Children's Hospital
Information provided by (Responsible Party):
Soma Jyonouchi, Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT00774358
First received: October 16, 2008
Last updated: June 26, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)